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Resumo 
O tratamento do cancro do osso geralmente origina defeitos ósseos com células tumorais 
residuais que proliferam durante a regeneração óssea. Portanto, é necessária uma estrutura para a 
regeneração óssea que simultaneamente mate células tumorais residuais. Este projeto visa produ-
zir um sistema composto por um vidro bioativo (BAG) e nanopartículas magnéticas (MNPs). Este 
sistema é altamente bioativo e reabsorvível devido ao vidro bioativo que leva à formação da ca-
mada de hidroxiapatite (HA) que faz uma ligação entre o material e o osso. As nanopartículas 
magnéticas atuam como sementes gerando calor clinicamente relevante, sob aplicação de um 
campo magnético alternado, para matar ou sensibilizar células tumorais. Em combinação com a 
liberação de um fármaco citotóxico, este sistema compósito efetivamente irá matar as células do 
tumor ósseo enquanto fornece a base para a regeneração óssea. 
O BAG foi produzido por uma técnica simples de sol-gel assistida por EISA (Evaporation 
induced self-assembly). Um moinho de bolas foi utilizado para diminuir o tamanho das partículas 
do BAG e aumentar sua dispersabilidade. Os pós foram caracterizados por SEM (microscopia 
eletrônica de varrimento), EDS (espectroscopia de dispersão de energia por raios X), e FTIR (Es-
pectroscopia por Infravermelho com Transformada de Fourier. As IONPs foram produzidas por 
co-precipitação química e revestidas com ácido oleico para evitar a agregação e a perda de pro-
priedades superparamagnéticas com o tempo. As membranas de PVP/BAG foram produzidas por 
eletrofiação e os parâmetros foram otimizados de modo a produzir fibras de diâmetros menores, 
uma vez que isto se traduz numa maior área de superfície e maior bioatividade. Os IONPs foram 
então incorporados na solução por agitação mecânica. 
As membranas eletrofiadas foram reticuladas devido à solubilidade do PVP em água. Para 
tal foi utilizada a reticulação por UV e térmica, mas apenas a reticulação térmica provou ser bem-
sucedida. Neste aspeto, a análise TGA/DSC foi importante para encontrar a temperatura de reti-
culação do PVP e forneceu algumas informações sobre a estabilidade térmica das membranas. 
As membranas compósitas insolúveis em água foram testadas para aplicação em hiperter-
mia magnética e a sua citotoxicidade foi também avaliada. As IONPs provaram ter propriedades 
superparamagnéticas e uma pequena variação de temperatura foi alcançada para uma amostra de 
10 mg de membrana, demonstrando o potencial das membranas compósitas para esta aplicação.  
Palavras-chave: Hipertermia magnética, membranas compósitas, nanopartículas de óxido 
de ferro, regeneração óssea, vidro bioactivo. 
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Abstract 
Bone cancer treatment usually originates bone defects with residual tumour cells that can 
proliferate during bone regeneration. Therefore, a scaffold for bone regeneration that simultane-
ously kill residual tumour cells is needed. This project aims at producing a composite system 
composed of a bioactive glass (BAG) and magnetic nanoparticles (MNPs). This system is highly 
bioactive and reabsorbable due to the bioactive glass which leads to formation of a hydroxyapatite 
(HA) layer that bonds to bone. The system is biodegradable at an adequate rate for bone regener-
ation. Magnetic nanoparticles act as thermoseeds generating clinically relevant heat under an ap-
plied alternating magnetic field to kill or sensitize tumour cells. In combination with release of an 
anticancer drug, this composite system will effectively kill bone tumour cells whilst providing a 
base for bone regeneration. 
BAG was produced by a simple sol-gel technique assisted by EISA (Evaporation Induced 
Self-Assembly). Ball milling equipment was used to decrease the BAG particle size and increase 
its dispersibility. The powders were characterized by SEM (scanning electron microscopy), EDS 
(energy dispersive x-ray spectroscopy), and FTIR (Fourier Transform Infrared Spectroscopy). 
IONPs were produced through chemical co-precipitation and coated with oleic acid to avoid ag-
gregation and loss of superparamagnetic properties over time. First, PVP/BAG composite mem-
branes were produced by electrospinning and the parameters were optimized to produce smaller 
fibres as it translates into higher surface area and higher bioactivity. IONPs were then incorpo-
rated in the solution.  
The electrospun membranes were crosslinked due to the PVP water-soluble characteristic. 
UV and thermal crosslinking were employed, but only thermal crosslinking proved to be success-
ful. For this to be successful TGA/DSC was helpful to find the crosslinking temperature and pro-
vided information about the thermal stability of the membranes. 
Water-insoluble membranes were tested for magnetic hyperthermia application and cyto-
toxicity assays were also performed. The IONPs proved to have superparamagnetic properties 
and a small temperature variation was achieved for a 10 mg membrane sample, which proved the 
potential of composite membranes for this application. 
Keywords: Bioactive glass, bone regeneration, composite membranes, iron oxide nano-
particles, magnetic hyperthermia. 
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1 Motivation and objectives 
Cancer is a global problem with an increasing incidence every year. In particular, bone 
cancer has a high incidence and related death in young groups. Bone is also the third most frequent 
site of metastasis, after lung and liver, which reflects the high incidence of bone injuries. Bone 
cancer treatment usually originates bone defects with residual tumour cells that can proliferate 
during bone regeneration. Therefore, a scaffold for bone regeneration that simultaneously kill 
residual tumour cells is needed. 
In the Biomaterials group the research is focused in developing new composite materials 
for biomedical applications. One of the main research areas is the development of multifunctional 
magnetic nanoparticles for cancer theranostic through a combination of magnetic hyperthermia, 
controlled drug delivery and diagnostic by magnetic resonance imaging. On another research line, 
the group has focused on the development of composite materials for bone tissue engineering. 
More recently, a PhD student started to develop a 3D composite system composed of bioactive 
glasses (BAGs), magnetic nanoparticles and a capsule of electrospun fibres. This system is highly 
bioactive and resorbable due to the bioactive glass which leads to formation of a hydroxyapatite 
layer that bonds to collagen fibrils. The system is biodegradable at an adequate rate for bone 
regeneration. BAGs are greatly known for their bioactive properties and ability to induce bone 
and tissue regeneration. They have also been electrospun into fibrous membranes, with suitable 
diameters and great surface area that further improve their bioactivity when compared to BAG in 
the form of powder, so a BAG fibrous membrane represents a very good candidate to incorporate 
the MNPs for hyperthermia treatments. A biocompatible polymer like Polyvinylpyrrolidone 
(PVP) may be used to help properly produce these membranes, through electrospinning tech-
nique. Magnetic nanoparticles act as thermoseeds generating clinically relevant heat under an 
applied alternating magnetic field to kill or sensitize tumour cells. In combination with release of 
an anticancer drug, this composite system will effectively kill bone tumour cells whilst providing 
a base for bone regeneration. 
In this thesis the main objective is to produce by electrospinning a composite membrane 
composed of bioactive glass, a biocompatible and biodegradable polymer with magnetic nano-
particles incorporated. This composite membrane should be bioactive and be suitable for mag-
netic hyperthermia application, making a proof of concept of a material that can aid the regener-
ation of bone and simultaneously kills cancer cells by magnetic hyperthermia in the tumour site. 
To achieve such objective, the following topics were addressed: 
 Study the influence of electrospinning parameters in the production of polymer/bi-
oactive glass fibres; 
 Optimize bioactive glass concentration (as the bioactive glass will be majorly re-
sponsible for the bioactive properties of the composite) in the fibres; 
 Successfully incorporate magnetic nanoparticles in the composite membrane, to 
properly induce magnetic hyperthermia treatment 
 Study the biomedical application of the produced composite membranes by per-
forming cytotoxicity studies, bioactivity studies and magnetic hyperthermia stud-
ies. 
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2 Introduction 
2.1 Scientific context 
Current cancer treatments are based on surgery, radiotherapy (RT), chemotherapy (CT) and 
biological therapies [1]. Radiotherapy uses high-energy rays or particles to kill cancer cells, but 
most bone cancers are not easily killed by radiation, and high doses are needed. This can damage 
nearby healthy tissues and structures like nerves and blood vessels. Consequently, radiotherapy 
is not used as a main treatment for most bone tumours, but it is used to slow the growth of cancer 
cells generated due to bone metastases [2]. Chemotherapy consists in using systemic drugs to kill 
cancer cells all over the body. This treatment option is limited for larger tumours (like most bone 
cancers) because the treatment is not localized and healthy cells are very sensitive to current 
chemotherapy drugs, therefore it is not a very effective method for bone cancer treatment [1], [2]. 
An alternative treatment that has been studied these past years is hyperthermia (HT) with 
the help of magnetic nanoparticles (MNPs). Magnetic HT works as a calculated increase of tem-
perature in the human body, within the range of 40-44 ºC, by applying an electromagnetic stimu-
lus on magnetic nanoparticles that act like thermoseeds. Their efficiency can be measured by the 
ability to reach and accumulate on the tumour area [3]. This temperature increase leads to tumour 
cell death which are more sensitive to heat than normal tissues. Clinical application of hyperther-
mia is not established as a single treatment modality but as a way to improve chemotherapy and 
radiotherapy results, when applied in repetitively short intervals [4]–[6]. 
In order to adequately perform localized magnetic hyperthermia in an affected area it is 
important to find new alternatives that ensure the presence of NPs in the tumour region without 
any cytotoxic effect. A biocompatible, bioactive membrane with trapped NPs may represent a 
good alternative as it avoids the leakage of NPs in the targeted area. 
2.2 Magnetic Nanoparticles 
Magnetic Nanoparticles have been widely studied for biomedical applications as contrast 
agents for magnetic resonance imaging (MRI) and as hyperthermia agents for cancer treatment. 
[20]. There are different types of MNPs, generally composed of pure metals, metal alloys or metal 
oxides. From all of those, Iron Oxide NPs (IONPs) specifically Fe3O4 (magnetite) have shown 
superior biocompatibility and stability and are the most commonly used magnetic NPs for bio-
medical applications. MNPs physicochemical properties are size-dependent and in proper condi-
tions are able to generate heat when subjected to an alternating magnetic field (AMF), due to 
energy losses during the demagnetization process, which is crucial for HT [7]. 
A ferromagnetic NP with size smaller than 20 nm often contains a single magnetic domain 
with one collective magnetization direction (Figure 2.1 A). Once these NPs are placed under an 
external magnetic field (H), their magnetization directions can be aligned along the field direction 
to achieve magnetic saturation with overall magnetization reaching the saturation magnetization 
(MS) (Figure 2.1 B and C). When the size of a ferromagnetic NP is reduced to a level where the 
thermal energy is comparable to the magnetic anisotropy energy, this NP is magnetically unstable 
and is said to be superparamagnetic[8]. A group of superparamagnetic NPs can be easily magnet-
4 
ized (with large susceptibility) to reach MS, but they have no coercivity and remnant magnetiza-
tion (Figure 2.1 D). Magnetic NPs in the superparamagnetic state have much weaker magnetic 
dipole interactions and therefore are readily stabilized and dispersed in liquid media [9]. 
 
Figure 2.1. Schematic illustration of (A) a single domain magnetic NP with its magnetization pointing to 
one direction, (B) a group of single domain magnetic NPs aligned along a magnetic field direction, (C) the 
hysteresis loop of a group of ferromagnetic NPs, and (D) the hysteresis loop of a group of superparamag-
netic NPs. (Adapted with permission from [9]. Copyright 2011 American Chemical Society) 
The frictions caused by the physical rotation of a NP, Brownian relaxation, and the mag-
netization reversal within the NP, Néel relaxation, lead to the loss of magnetic energy and the 
generation of thermal energy. The heating power of these NPs is directly related to the ferromag-
netic hysteresis area and frequency of the alternating magnetic field [10]. To ensure better thermal 
effects under the common hyperthermia conditions, magnetic NPs should have small coercivity, 
large susceptibility, and high MS. The NP heating efficiency is measured by the specific absorp-
tion rate (SAR, W.g-1). For practical therapeutic applications with minimized side effects, it is 
critically important to obtain optimum heating efficiency to reach the desired hyperthermia tem-
perature at 41-44 ºC [9]. MNPs stability in physiological conditions can limit their desired per-
formance. The size of MNPs is the crucial factor determining their uptake of target cell and elim-
ination from the body. For example MNPs which have the diameter size larger than 200 nm are 
retained in the spleen and liver while particles of smaller sizes than 10 nm are rapidly removed 
via renal clearance [3]. In order to avoid that, several reports on MNPs coating with molecules 
like oleic acid (OA) or dimercaptosuccinic acid (DMSA) have been successful on stabilizing the 
MNPs and preventing their aggregation as they create repulsive forces, mainly stereo chemical 
repulsions, that compensate the attractive magnetic and van der walls forces [4] [7]. 
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2.3 Bioactive glasses 
Bioactive glasses are a class of biomaterial with increased interest along the years. BAGs 
form a hydroxyapatite (HA) layer on the biomaterial when implanted in the human body through 
glass dissolution. HA is the inorganic part of human bone and therefore BAGs are able to bond 
and form a stable interface with bone tissues while being biodegradable and stimulating bone 
regeneration [11]–[13]. The first form of BAG was Larry Hench’s 45S5 Bio-glass (commercial 
name) with a 45 wt.% SiO2, 24.5 wt.% CaO, 24.5 wt.% Na2O, and 6.0 wt.% P2O5 composition 
(wt.% represents the molecular weight percentage), produced by a melt quenching synthesis and 
presented in the late 1960´s [11]. Since then, many different compositions of bio-glass and their 
in vitro and in vivo behaviour has studied. 
There are different techniques available in literature to produce BAG. Melt quenching is a 
process that requires temperatures up to 1300-1400 ºC and only bio glasses produced with less 
than 60 wt.% of SiO2 show bioactivity in in vivo conditions. Above that level of wt.% of SiO2 the 
material does not develop a HA layer and does not bond to bone or soft tissues. The major alter-
native process to melt quenching is the Sol-Gel technique which is a lower temperature process. 
This process enables the production of a larger range of bio glass compositions, up to 90 wt.% 
SiO2, with similar biological response to the ones produced by melt quenching [14], [15]. Sol–
gel BAGs exhibit higher rates of apatite phase formation, faster bone bonding and excellent deg-
radation and resorption properties [16]. 
In order to enhance bioactivity, both composition and structure are important in BAGs de-
rived from sol-gel. A better control of properties like specific surface area and pore volume can 
increase the bioactive response, so it is important to control the overall porosity and pore structure 
of the material. In 2004, Yan et al. [13] pioneered the synthesis of mesoporous BAGs with SiO2-
CaO-P2O5 system, breaking ground for the development of BAGs with superior bioactivity com-
pared to conventional melt-derived and sol-gel materials. 
2.4 Silica-based BAG Polymeric Fibrous Membrane 
In order to induce proper bone regrowth, the materials that compose the scaffold must be 
biocompatible and the scaffold itself should provide proper environment to stimulate new bone 
production. Allowing cells and blood vessels to spread through the scaffold is very important and 
for that, a certain level of macro/microporosity is necessary. 
Silica-based BAGs are able to bond and create a stable interface with living bone tissue 
without promoting inflammation or toxicity [17]. Their main advantage to be used in bone regen-
eration is their high bioactivity, which allows BAGs to create an apatite-like phase, similar to the 
inorganic part of the bone, when in contact with physiological fluids. Also the degradation of 
these BAGs have shown osteoconductive properties, which means that bone tissue grows on BAG 
surface [18], [19]. The reaction at BAG surface when in contact with body fluids is illustrated in 
Figure 2.2 and described elsewhere [20]. 
In order to produce BAGs with high surface area and high porosity at low temperatures, 
both crucial for high bioactivity, the sol-gel process has been widely used and studied along the 
years. During the sol–gel process, the gelling stage occurs at room temperature. Bioactive glasses 
can be made by sol–gel processing, thus facilitating the incorporation of organic and biological 
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molecules within the network, or even cells within silica matrices [18]. Moreover, sol–gel pro-
cesses can be combined with supramolecular chemistry of surfactants, resulting in a new highly 
ordered mesoporous material for biomedical applications. Yan et al. [13] compared conventional 
sol-gel BAGs to new sol-gel BAGs with non-ionic triblock co-polymers Pluronic 123 and Plu-
ronic 127 assisted by Evaporation Induced Self-Assembly (EISA). The EISA process is based on 
preferential evaporation of the solvent which progressively enriches the concentrations of non-
volatile solution constituents and finally ordered mesophase occurs. The surfactant molecules 
self-organize into micelles that link the hydrolysed silica precursors trough the hydrophilic com-
ponent and self-assemble to form an ordered mesophase[21]. After gelling, drying and surfactant 
calcinations, bioactive mesoporous glasses (MBG) were obtained. It was also revealed by scan-
ning electron microscopy (SEM) analysis that the bioactivity of MBG strongly depends on MBG 
composition. 80S15Ca5P MBG showed a bigger bioactivity than 70S25C5P, 60S35C5P, 100S 
by decreasing order [13]. 
 
Figure 2.2. Bioactive Glass surface reaction and bone regeneration mechanism [20]. 
Among the different BAG structures produced, MBGs of nanofibrous structure present two 
advantages: at microscopic level the ultrathin fibres have highly specific surface areas and at 
macroscopic scale, due to their long length, the nanofibres can be assembled in 3D membranes 
with an interconnected macroporous network [22], [23]. 
2.5 Electrospinning technique 
Nano fibrous membranes can be obtained by several techniques such as drawing, templates 
synthesis, phase separation, self-assembly and electrospinning [22]. From these, electrospinning 
stands out as being the most accessible, versatile, low cost and relatively fast compared to the 
previous mentioned techniques. 
Electrospinning is a broadly used technology for fibre formation which uses electrical 
forces to produce nano or micro polymer fibres. In a conventional electrospinning setup (Figure 
2.3), the solution passes through a needle and a high voltage is applied. At a critical voltage the 
repulsive force of the charged particles within the solution, overcomes the surface tension of the 
solution and a jet erupts from the tip of the needle towards a grounded collector. The fibres mor-
phology will depend on the solution properties (viscosity, conductivity and surface tension); flow 
rate of the solution, voltage applied to the needle, distance between the needle and collector and 
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finally temperature and humidity. Electrospinning requires a viscoelastic solution that has the 
ability to stretch under high elongation forces, while resisting break-up, so the use of a polymer 
like PVA, PVP or PEO is often needed in order to guarantee electrospun fibres [24]. 
 
Figure 2.3. Schematic illustration of electrospinning setup. 
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3 Materials and Methods 
3.1 Synthesis of BAG by Sol-Gel and Ball Milling 
BAG powders were produced by a simple sol-gel process assisted by EISA using tetraethyl 
orthosilicate (C4H20O4Si, TEOS, Sigma-Aldrich), calcium nitrate (Ca(NO3)2, VWR Chemicals), 
and triethyl phosphate ((C2H5O)3PO, TEP, Fluka) as inorganic precursors, Pluronic F127 (Mw 
12000 Da, Sigma-Aldrich) as the structure-directing agent, and ethanol (Sigma-Aldrich, 99.8%) 
as solvent. The amount of inorganic precursors was calculated in order to obtain a ratio of 
80Si:15Ca:5P (representing the molar fraction of Si, Ca and P). 
The process was adapted from the work of Yan [13]. First, 1.84 g of F127 were dissolved 
in a 60 g of ethanol. 6.7 g TEOS, 0.73 g TEP and 1.4 g Ca(NO3)2 were added in this order, with 
a 1 ml of 0,5 M HCl solution being added at last. The final solution was kept at room temperature 
under magnetic stirring for 24 h. To completely dry the gel, the resulting sample was kept at 60 
ºC until total evaporation of ethanol. The final mesostructured product was shattered by a ball 
milling technique using the Planetary Mono Mill “pulverisette 6”, Fritsch for 6 h. The powders 
were uniformly grinded by planetary ball mill, with zirconia balls with 1500 RPM in grinding 
periods of 30 min, to avoid the equipment overheating. At last, the powders were left to dry and 
were prepared. Measures of the powder were taken before and after 6 h of grinding. 
3.2 Synthesis of iron oxide nanoparticles stabilized with oleic acid 
IONPs were produced by chemical co-precipitation technique as described by Matos et al. 
[4]. Iron chloride tetrahydrate (FeCl2.4H2O, 2.5 mmol, Sigma-Aldrich) and iron chloride hexahy-
drate (FeCl3.6H2O, 5 mmol, Sigma-Aldrich) were mixed in ultrapure water (Míli-Q) followed by 
addition of an ammonium solution (NH4OH at 25 %, 10 ml, Panreac) to precipitate the IONPs in 
the absence of oxygen (by bubbling N2). The amount of oleic acid was calculated as a percentage 
of the NPs mass [7], followed by ultrasonic bath during 3 h to ensure the coating of all IONPs. 
To remove the excess of oleic acid, the suspension was in dialysis until pH 7. 
3.3 Fabrication of polymeric fibrous magnetic membranes by electro-
spinning 
The electrospinning solution was prepared using polyvinylpyrrolidone (PVP, Mw 
1 300 000 Da, Sigma-Aldrich) as an auxiliary polymer to adjust the solution viscosity and to 
promote fibre formation [25]. A 14 wt.% BAG and 14 wt.% PVP (both relative to ethanol mass) 
solution was prepared using magnetic stirring and ultrasounds to uniformly disperse the BAG 
particles. The high voltage source used for the electrospinning process was a Glassman EL 30kV, 
which was connected to the metal needle through the positive pole, and the ground with the col-
lector. The infuser pump, which had a constant flow rate, was a KDS100 KD Scientific. The 
solution was always carefully introduced into a 1 ml syringe, with an internal diameter of 4.50 
mm. As for the metal needles used, a 21 G gauge needle was always used in this work. The fibres 
were collected on an aluminium foil, with the collector being motionless. All equipment was 
wrapped in an acrylic box for a better control over the environmental parameters of the process, 
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with the natural humidity of the laboratory being around 30-40%. Fibres production was opti-
mized by varying the flow rate, applied voltage and distance to the collector at controlled humid-
ity and temperature (Table 6.1 in Supplementary information). Furthermore, IONPs were added 
to the ethanol/PVP/BAG system to achieve a 4 wt.% IONPs (wt.% relative to the polymer mass). 
PVP is highly soluble in water and therefore not suitable for biological applications. There-
fore, PVP membranes were crosslinked by thermal crosslinking with temperatures of 150 ºC, 
175 ºC and 200 ºC for times of 5, 10, 15, 20 and 24 h using the Nabertherm High Temperature 
Furnace HTCT 01/16/P330 LC011H6SN and also by UV radiation crosslinking using a Vilber 
Lourmat™ Biolink™ BLX UV Crosslinker for 1, 2, 3, 4, 5 and 6 h. 
3.4 Characterization 
Scanning electron microscopy (SEM) was performed using a Carl Zeiss Auriga SEM 
equipment to analyse fibre morphology. The samples were coated with a thin layer of gold and 
palladium. Additionally, Energy Dispersive Spectroscopy (EDS) using Oxford Instruments EDS 
was performed to detect the presence of BAG and iron elements in the fibres. FTIR spectra of the 
samples were obtained using a Nicolet 6700–Thermo Electron Corporation Attenuated Total Re-
flectance-Fourier Transform Infrared spectrometer (ATR-FTIR). Measurements were performed 
in freeze-dried samples in the range of 480–4000 cm−1 with a resolution of 2 cm−1. Thermograv-
imetric analysis (TGA) and differential thermal analysis (DTA) studies were carried out using a 
Thermal Analyzer NETZSCH STA 449 F3 Jupiter® at a rate of 10 ºC.min−1 in a N2 atmosphere. 
3.5 Magnetic Hyperthermia assays 
Magnetic hyperthermia measurements were obtained using the equipment NanoScale Bio-
magnetics, DM100 Series. The heating capacity of 10 mg of the membranes immersed in 1 ml of 
ultrapure water with incorporated IONPs were tested. Measurements were performed for 10 min 
maintaining the magnetic flux density at 24 kA.m-1 and the frequency at 418.5 kHz. 
3.6 Bioactivity 
Simulated body fluid (SBF) was prepared according to the procedure given by Kokubo et 
al. [26], [27]. Square samples of 1 cm2 and 5 mg were immersed in 20 ml of SBF for 6, 12, 24, 
48 and 72 h. During this time, the samples were placed in an incubator at 37 ºC to mimic physio-
logical temperature. After the stipulated time, samples were removed and washed with Millipore 
water and dried in air. The samples were then observed in SEM. 
3.7 Cytotoxicity Assays 
To evaluate the cytotoxicity of the membranes, the assays were performed according to 
standard ISO-10993 Biological evaluation of medical devices, Part 5: Tests for in vitro cytotoxi-
city. The assays were performed using the extract method and Vero cells (monkey renal epithelial 
cells), as described elsewhere [4] and in the section 6.2 of supplementary information in detail. 
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4 Results and Discussion 
4.1 Preparation of the precursor materials 
The main objective of this thesis was to produce and characterize magnetic bioactive glass 
membranes and to test their application in magnetic hyperthermia. For that, two main precursor 
materials were used: iron oxide nanoparticles and bioactive glass. 
4.1.1 Iron oxide nanoparticles 
The IONPs used to produce the fibrous membrane were synthetized using a co-chemical 
precipitation technique that was previously optimized by the research group [28]. Due to the NPs 
low stability in aqueous solutions, they were coating with oleic acid. These NPs were extensively 
characterized in another published work [4]. For some contextualization, we present the most 
relevant results for this dissertation. Uncoated IONPs are spherical and have an average diameter 
of 9.4 ± 1.9 nm. The coating of these NPs with oleic acid did not show any influence in particles 
size or morphology. IONPs crystallinity was studied by XRD showing the presence of magnetite 
characteristic peaks with a crystalline cubic structure. Again, the presence of the surfactants did 
not alter the crystalline structure of the IONPs. 
4.1.2 Bioactive glass 80Si15Ca5P 
In this work BAG was produced by sol-gel technique assisted by EISA using Pluronic F127 
as the structure-directing agent. The amount of inorganic precursors was calculated to obtain a 
ratio of 80Si:15Ca:5P (representing the molar fraction of Si, Ca and P). Figure 4.1 illustrates the 
obtained BAG which behaves like a gel and can be easily extruded by a syringe. 
 
Figure 4.1. Bioactive glass obtained by sol-gel - EISA process using with a structure-directing agent (Plu-
ronic F127). 
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The first step to characterize the obtained BAG was to confirm its atomic composition, i.e., 
to confirm if the final molar ratio was 80Si:15Ca:5P. For that, BAG powder was observed with 
SEM and EDS not only to analyse its structure but also to evaluate the composition elements and 
atomic concentration of BAG. Figure 4.2 represents SEM image of as-produced BAG and the 
respective EDS analysis through the element spectrum, the atomic and weight % of each element.  
In the SEM image BAG powder shows different particle sizes. The powder does not seem 
to present any kind of porosity, because unlike most common BAG, this one is not sintered to 
remove the structural agent. The EDS element spectrum confirms that the as-synthesized BAG is 
composed by Si, Ca, P, O and C. To determine the weight concentration of Si, Ca and P (the 
elements responsible for the BAG properties), the elements O and C were ignored. Consequently, 
an 80,02 % of Si, 16.34 % of Ca and 3.65 % of P atomic composition was confirmed which is 
very similar to the desired ratio of 80Si:15Ca:5P. 
 
Figure 4.2. SEM of BAG powders and the respective EDS element spectrum, elements atomic and weight 
concentration through EDS. The picture was taken in a 15 KV mode with a backscattered electron detector. 
To analyse the chemical composition of BAG powders, FTIR analysed was performed. 
Figure 4.3 shows the comparison of BAG and Pluronic F127 spectrum. In BAG spectrum, the 
band at 566 cm-1 is assigned to the Si-O-Si rocking mode, while the band at 788 cm-1 is attributed 
to the SiO4 bending vibration. The band at 956 cm-1 may be attributed to the Si-OH bending 
vibration but it is unclear due to a similar peak in Pluronic F127. Moreover, the band at 1025 cm-
1 is associated with the PO43- asymmetric stretching mode (characteristic of BAG), while the band 
at 1090 cm-1 is usually assigned to the Si-O-Si stretching vibration, however F127 also has a 
similar band in the same wavenumber. The band in 1340 cm-1 is an O-H in-plane bending char-
acteristic of F127. Finally, the band at 1645 cm-1 is assigned to the stretching vibrations of surface 
adsorbed water. At 2890 cm-1 a small band is attributed to the OH- stretching mode. 
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Figure 4.3. FTIR spectra of BAG and Pluronic F127. 
4.2 Production of composite membranes by electrospinning 
Initially, a study was carried out to evaluate the parameters effect on the electrospinning 
process (applied voltage, flow rate and needle-collector distance) to determine the ideal parame-
ters for the production of PVP membranes. This work was made in parallel by a PhD. student 
using the design of experiences and the response surface methodology to obtain the smaller fibre 
diameter. In this work, the smaller diameters are considered the most suitable because smaller 
fibre diameter leads to higher surface area which is directly related to a higher bioactivity/biodeg-
radation. Figure 4.4 shows the 18 wt.% PVP membrane produced in the referred study and the 
respective SEM image with an average fibre diameter of 668 ± 191 nm. The electrospinning pa-
rameters 20 kV, 20 cm and 0,10 ml/h were taken into consideration while choosing the test pa-
rameters for the composite membranes of PVP and BAG. 
4.2.1 Composite membranes of PVP and BAG 
Based of the best set of parameters obtained from the previous study, the composite mem-
branes of PVP and BAG were produced using a PVP concentration of 18 wt.% with different 
BAG concentrations (1; 2; 3; 4; and 5 wt.%). The main purpose of this step was to evaluate BAG 
effect on fibres morphology and electrospinning conditions. For this set of experiences 2 flow 
rates (0.2 and 0.4 ml.h-1); 2 applied voltages (15 and 20 kV) and 2 different needle-collector dis-
tances (15 and 20 cm) were used with controlled humidity and temperature during 15 min of fibre 
deposition. The average fibre diameters were obtained from SEM images using ImageJ Software, 
by measuring at least 30 single fibres from each collected image. The average fibre diameters are 
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presented in Table 4.1 and the complete information (correspondence between sample code (A-
E) and tested parameters) can be consulted in Table 6.1 in supplementary information. 
 
Figure 4.4. (left) Representative image of a 18% PVP membrane obtained from the design of experiences 
study. (right) Corresponding SEM image of the same membrane. The used electrospinning parameters to 
produce this membrane were 20 kV; 20 cm and 0,1 ml/h. 
Table 4.1. Average diameter of electrospun fibres obtained from PVP and BAG mixtures. Results are pre-
sented as average diameter ± standard deviation calculated from at least 30 measures. Samples codes (A1 
to E8) correspond to a set of electrospinning parameters, which can be consulted in Table 6.1 in supple-
mentary information. (The blank spots represent samples that were not possible to properly visualize with 
this technique)  
Sample 
Average diameter 
(nm) 
Sample 
Average diameter 
(nm) 
Sample 
Average diameter 
(nm) 
A1  C1 336 ± 72 E1 365 ± 51 
A2  C2 426 ± 128 E2 360 ± 56 
A3 483±144 C3 426 ± 107 E3 368 ± 125 
A4 457 ± 104 C4 474 ± 148 E4 374 ± 60 
A5 354 ± 69 C5 325 ± 64 E5 421 ± 67 
A6 349 ± 101 C6  E6 337 ± 53 
A7 368±87 C7 405 ± 121 E7  
A8 349 ± 115 C8 399 ± 77 E8  
      
B1 383 ± 94 D1 350 ± 63   
B2 353±90 D2 373 ± 95   
B3 531 ± 175 D3 442 ± 87   
B4 433 ± 115 D4 409 ± 108   
B5 411 ± 131 D5 347 ± 70   
B6 342 ± 82 D6 446 ± 95   
B7 490 ± 141 D7 308 ± 45   
B8 396 ± 107 D8 412 ± 94   
 
The number of samples with different electrospinning parameters is too low to determine 
the ideal conditions. However, it is possible to say that the parameters 15 kV, 15 cm and 0,2 ml/h 
(samples A1, B1, C1, D1, E1) produced, on average, smaller diameters with a smaller standard 
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deviation, which means higher uniformity. No significant differences were found samples with 
different BAG wt. % using the same electrospinning conditions. This indicates that it is possible 
to increase BAG concentration without significantly affect the average fibre diameter. 
However, some defects were found in the composite fibres with the increase of BAG con-
centration. Most samples presented fibres with regular shape, but some dispersed BAG particles 
(Figure 4.5 (a)) were visible in some areas of the membrane. Moreover, were also found branched 
fibres (Figure 4.5 (b)), plane fibres (Figure 4.5 (c)), and deformed fibres (Figure 4.5 (d)). The 
humidity percentage was lower than 30 % for all these samples. In a low humidity environment, 
the ejected solvent can evaporate too quickly and cause the phenomenon responsible for these 
irregular fibres described in literature [29]. Higher applied voltages (around 20 kV) can also cause 
some electrical instability that could also explain these deformations [29]. In addition, BAG par-
ticles are not very well dispersed in the membrane and there is a big discrepancy between particles 
sizes as it is observed in Figure 4.5 (a) and (d). 
 
Figure 4.5. Sample E2 (a), branched fibres in sample B3 (b), flat fibres in sample D4 (c) and deformed 
fibres in sample D4 (d) 
From this analysis, it was concluded that the humidity levels should a slightly higher, above 
30 % to avoid fibre defects. Moreover, BAG concentration can be increased at least up to 5 wt.%; 
however, particles should have uniform sizes and should be more dispersed within the membrane. 
The higher dispersity of particles in the membrane can be explained by particle size. After 
complete drying, BAG powders were manually grinded using a grinder and mortar. Using this 
procedure, the obtained BAG particles had a particle size of around 549 μm. This powder was 
further incorporated into the electrospun solution. However, after these initials attempts of pro-
ducing the electrospun membranes, it was obvious through SEM analysis that the BAG particles 
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size had to be reduced, to promote the homogeneous dispersion of BAG in the membrane. To 
reduce particle size a ball mill process was used for 6 hours. The particle size analyser proved the 
particle size reduction from 549 μm (before) to 26 μm (after 6 h), which is represented in Figure 
4.6. Although some aggregates are still present, the average particle size was greatly reduced to 
a factor of around 20 times its initial size. 
 
Figure 4.6. Particle size distribution of BAG powders before and after 6 h of ball milling process. 
After realizing that BAG content in the electrospun solution could be increased, a solution 
of 18 wt.% PVP with 9 wt.% BAG was prepared and electrospun. Using an optical microscope, 
the presence of electrospun fibres were confirmed. Since a content of 9 wt.% of BAG was easily 
dispersible in the 18 wt.% PVP solution, a test was made by doubling BAG concentration. The 
prepared solution with PVP and BAG at 18 wt.% each was extremely hard to disperse and with a 
unsuitable viscosity for electrospinning. Therefore, both PVP and BAG concentration was 
brought down to 14 wt.% each. This was an easily dispersible solution but when tested in elec-
trospinning, the solvent (ethanol) was evaporating too quickly, not allowing a proper fibre depo-
sition. Consequently, instead of forming a membrane, this solution produced a 3D structure. Since 
this was not the purpose of this thesis, the solvent was changed to a mixture of ethanol:water in a 
ratio of 85:15 (v/v). Since the concentrations and solvent were changed, the electrospinning pa-
rameters were again optimized to obtain fibres without defects and with the smallest diameter. 
The set of experiments, as well as the studied parameters can be found in and Table 6.2 in sup-
plementary information. The criteria for choosing the flow rates (0.05; 0.15; 0.25 ml/h) was based 
on the droplet accumulation on the needle tip. These droplets are to avoid in an ideal electrospin-
ning process, as they can cause big defects on the membrane if the droplet is ejected. If the droplet 
is not ejected from the needle, this represents a waste of solution and proves the non-ideal effi-
ciency of the process. The applied voltage and needle–collector distance were kept at 15 and 20 
kV and 15 and 20 cm, respectively, with intermediate values of 18.3 kV and 18 cm. 
The fibres diameters were measured in the same way as before and the results were ar-
ranged to facilitate the comprehension of the influence of each process parameter. Table 4.2 
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shows the influence of flow rate in the average fibre diameter (nm) of samples with PVP 14 wt.% 
and BAG 14 wt.% in an 85:15 ethanol:water solvent. At a flow rate of 0.25 ml/h a droplet on the 
needle tip starts to form, which causes instability of the ejected fibres and can explain why there 
is a tendency to produce higher fibre diameters. Using lower flow rates (0,05 ml/h) smaller fibres 
are obtained when compared to a flow rate of 0.15 ml/h. Higher flow rates mean more material 
being ejected with slower drying time, prior to reaching the collector and lower stretching forces, 
thus explaining higher diameters. Although 0.05ml/h seems the best flow rate for this work pur-
pose, it takes too long to produce a 100 mg membrane. With a 0.15ml/h flow rate that times 
decreases 3 times, and combined with the 20 kV, 20 cm or 15 kV and 18 cm it can produce good 
quality fibres with smaller diameter and smaller standard deviation (around 410 ± 134 and 380 ± 
85 nm, respectively). 
Table 4.2. Influence of flow rate in the average fibre diameter (nm) of samples with PVP 14 wt.% and BAG 
14 wt.% in an 85:15 ethanol:water solvent. (The diameters were compared from left to right with the re-
spective colours) 
 Flow Rate (ml/h) 
Applied Voltage (kV) Distance (cm) 0.05 0.15 0.25 
15 
15   475 ± 90 
18 449 ± 102 380 ± 85 455 ± 123 
20 402 ± 116 470 ± 95 508 ± 108 
18,3 
15 561 ± 334 603 ± 232 537 ± 382 
18 518 ± 209 486 ± 122 544 ± 196 
20 417 ± 122 457 ± 188 536 ± 138 
20 
15 558 ± 219 616 ± 204 722 ± 204 
18 520 ± 142 608 ± 196 679 ± 377 
20 548 ± 274 410 ± 134 741 ± 353 
Smaller Diam. Intermediate Diam. Higher Diam 
 
Table 4.3 shows that influence of applied voltage in the average fibre diameter (nm) of 
samples with the same precursor solution. A lower applied voltage usually is responsible for 
smaller diameters and lower standard deviation. However, this subject is a little controversial, as 
researchers have proven that voltage does influence fibre diameter, but the level of significance 
varies with solution viscosity and needle-collector distance [30]. This can explain what happens 
on the samples with 0.15 ml/h and 20 cm, where the diameters increase with the increase of ap-
plied voltage. Besides, with 15 kV a droplet on the needle tip was also formed which can represent 
a significant waste of electrospinning solution. Finally, Table 4.4 shows the influence of the nee-
dle to collector distance (cm) in the average fibre diameter of samples with the same precursor 
solution. With the increase of needle to collector distance from 15 cm to 20 cm, fibres become 
thinner, as the ejected solvent has enough time to evaporate before reaching the collector and 
more time to stretch the fibre. 
From this study it can be concluded that for the solution of PVP 14 wt.% and BAG 14 wt.% 
in an 85:15 ethanol: water solvent the flow rate of 0.05 ml/h produces the smallest average fibre 
diameter. However, it takes too long to produce a membrane compared to higher flow rates of 
0.15 ml/h and 0.25 ml/h. Of these two, 0.15 ml/h shows the smallest average fibre diameter com-
pared to the ones from 0.25 ml/h. In terms of distance from needle to collector, 20 cm is the best 
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parameter (compared to 15 and 18 cm) to produce smallest fibre diameter, as well as it decreases 
the standard deviation, which means a more homogeneous membrane. This is due to the ejected 
solution having more time to elongate. Regarding the applied voltage, 15 kV produces smaller 
fibres, but most of the electrospinning solution is not properly ejected, as the voltage is not enough 
to overcome the surface tension of the solution, and it accumulates on the tip of the needle in form 
of droplets. The droplets may cause defects on membrane if ejected to the collector, and if not 
ejected it ends up being material wasted. For this reason, an applied voltage of 15 kV is too be 
avoided. Fixing the flow rate on 0,15 ml/h and the distance in 20 cm, it is clear that a 20 kV 
voltage produces better fibres than 18.3 kV. 
Table 4.3. Influence of applied voltage in the average fibre diameter (nm) of samples with PVP 14 wt.% 
and BAG 14 wt.% in an 85:15 ethanol:water solvent. 
 Applied Voltage (kV) 
Flow Rate (ml/h) 
Needle-Collector 
Distance (cm) 
15 18.3 20 
0.05 
15  561 ± 334 558 ± 219 
18 449 ± 102 518 ± 209 520 ± 142 
20 402 ± 116 417 ± 122 548 ± 274 
0.15 
15  603 ± 232 616 ± 204 
18 380 ± 85 486 ± 122 608 ± 196 
20 470 ± 95 457 ± 188 410 ± 134 
0.25 
15 475 ± 90 537 ± 382 722 ± 204 
18 455 ± 123 544 ± 196 679 ± 377 
20 508 ± 108 536 ± 138 741 ± 353 
 
Table 4.4. Influence of the needle to collector distance (cm) in the average fibre diameter (nm) of samples 
with PVP 14 wt.% and BAG 14 wt.% in an 85:15 ethanol:water solvent. 
 Needle-collector distance (cm) 
Applied Voltage (kV) Flow Rate (ml/h) 15 18,3 20 
15 
0.05  449 ± 102 402 ± 116 
0.15  380 ± 85 470 ± 95 
0.25 475 ± 90 455 ± 123 508 ± 108 
18.3 
0.05 561 ± 334 518 ± 209 417 ± 122 
0.15 603 ± 232 486 ± 122 457 ± 188 
0.25 537 ± 382 544 ± 196 536 ± 138 
20 
0.05 558 ± 219 520 ± 142 548 ± 274 
0.15 616 ± 204 608 ± 196 410 ± 134 
0.25 722 ± 204 679 ± 377 741 ± 353 
 
For these reasons, the parameters 0,15 ml/g flow rate; 20 cm distance and 20 kV applied 
voltage, were the chosen for producing the membranes as depicted in Figure 4.7. The membrane 
produced with these parameters had a average fibre diameter of 410 ± 169 nm with (what appears 
to be) small nuclei of BAG within. Some reports like [31] have achieved similar sizes in their 
studies. Most of fibres measured have diameters between 300 and 400 nm, however there are still 
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some fibres with over 700 nm, which increases the standard deviation and may be attributed to 
the high voltage (20 kV) used in the process. Compared to the 18% PVP membranes in the DOE 
referred above, these PVP, BAG membranes had smaller diameters for similar parameters. This 
may be attributed to the smaller PVP concentration (14 wt.%) in the PVP, BAG membranes, as 
it has been shown that solutions with lower polymeric concentration produce smaller fibre diam-
eters [31]. 
 
Figure 4.7. SEM image of fibres produced with PVP 14 wt.% and BAG 14 wt.% in an 85:15 ethanol:water 
solution and the following parameters: 20 kV, 20 cm and 0,15 ml/h (sample 18), and the respective size 
distribution graph. 
After the optimization of the electrospinning parameters, the composition of the obtained 
membranes was analysed. First, with the help of EDS equipment coupled to SEM, the atomic 
concentration and element maps were analysed to examine the presence of BAG within the fi-
brous scaffold. Figure 4.8 shows the SEM image of the PVP 14 wt.% and BAG 14 wt.% mem-
brane and the respective EDS elemental map. Analysing SEM image it is clear the presence of 
round shaped BAG particles trapped and mixed in the fibrous scaffold. These nuclei are majorly 
composed of silica, with presence of calcium and phosphorous. Ca and P also seem to be dispersed 
within the polymeric fibres. EDS also provides the quantification of both normal concentration 
and atomic concentration of the elements present on the spectrum (Figure 4.8 down right image). 
The atomic composition, 74.84 wt.% of Si, 17.64 wt.% of Ca and 7.66 wt.% of P is very close to 
the desired 80Si15Ca5P composition. 
Thermogravimetric analysis was carried out to study the thermal stability of PVP and the 
composite membranes. TGA of the PVP membrane (Figure 4.9 A) showed the first mass loss 
below 100 ºC corresponding to the 56 ºC exothermic peak in the DSC trace. This is associated 
with water adsorption and other alcohol by-products of the condensation reactions. A small mass 
loss continues until 340 ºC occurs, and the exothermic peak 185 ºC is believed to be related to the 
PVP reticulation, as it has been reported to be around between 150 ºC and 200 ºC [31]. Only at 
around 340 ºC PVP starts decomposing until around 460 ºC where only a residual mass percentage 
is left. Analysis of the thermal stability of composite membranes in Figure 4.9 B shows a first 
mass loss of 5.11 % until around 120 ºC corresponding to the exothermic peak at 59 ºC, which is 
attributed to the water adsorption and other alcohol by-products of the condensation reactions. A 
new mass loss of 122 % occurs from 120 ºC until around 380 ºC. From 150 ºC to 200 ºC the mass 
loss can be attributed to the PVP crosslinking, as it has been shown to happen around this area 
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[31]. From 200 ºC to 340 ºC the mass loss is attributed to the decomposition of F127. This de-
composition is reported to continue until 580 ºC in [32], but at 340 ºC the PVP in the membrane 
also starts decomposing very fast until 480 ºC. From there, a slow decomposition of residual PVP 
and F127 is believed to happen. 
 
Figure 4.8. SEM image of the PVP 14 wt.% and BAG 14 wt.% membrane (top, left), and the respective 
EDS elemental map (top, right). Normal and atomic Concentration (wt.% and at.%) quantification on the 
left down image. Element spectrum on the right down image (carbon and oxygen were ignored) (see Figure 
6.2 in supplementary information for complete information of the element colour trace). 
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Figure 4.9. DSC/TGA of plain PVP membrane (A) and of composite PVP 14 wt.% and BAG 14 wt.% 
membrane. 
From this analysis, it is possible to determine the PVP crosslinking temperature which is 
around 190 ºC for plain PVP membranes and a little bit higher for PVP+BAG membranes. Also, 
PVP and F127 components can be eliminated (if wanted) with temperatures around 500 ºC. 
4.2.2 Composite membranes of PVP, BAG and IONPs 
Previously synthesized IONPs were incorporated in the electrospinning solution by adding 
a known concentration to the PVP 14 wt.% BAG 14 wt.% solution in a concentration of 4 wt.% 
relative to the PVP mass. This solution was mixed by mechanical stirring for about 20 min. The 
following solution was electrospun with 20 kV; 20 cm; 0,15 ml/h with 35% relative humidity and 
25 ºC. 
The same analysis process was applied on the electrospun PVP/BAG/IONPs membrane. 
In Figure 4.10 a sample of the composite membrane was observed in SEM and EDS. The addition 
of IONPs seems to not influence the morphology of the fibres (Top, left). The EDS elemental 
map (top, middle) shows the presence of BAG components (Si, Ca, P) but also the clear presence 
of iron (top, right) from the IONPs added. The quantification of normal and atomic concentration 
(bottom left) is merely indicative of the presence of iron and does not translate to the overall 
normal and atomic concentration of the membrane. The small size of NPs (around 10 nm) makes 
it impossible to observe with this SEM equipment. Transmission Electron microscopy (TEM) 
analysis would be more suitable to observe the IONPs. 
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Figure 4.10. SEM image of the PVP 14 wt.%, BAG 14 wt.% and 4% IONPs membrane (top, left), and the 
respective EDS elemental map. Normal and atomic Concentration (wt.% and at.%) quantification on the 
left down image. Element spectrum on the right down image (carbon and oxygen were ignored) (see Figure 
6.3 in supplementary information for complete information of the element colour trace). 
4.2.3 Thermal and UV crosslinking of PVP membranes 
PVP is soluble in aqueous solutions, and consequently it is unsuitable for biomedical ap-
plications. To make PVP water-insoluble membranes, the polymer must be crosslinked. PVP 
crosslinking has been successfully reported by thermal treatment [31] and by UV treatment [33], 
with both stimulus enabling different polymer chains to link through a covalent or ionic bond, 
promoting changes in the polymer physical properties. 
For the UV crosslinking, a UV light was used. Plain PVP 18 wt.% membranes were sub-
mitted to different UV times: 30 min, 1, 2, 3, 4, 5 h. The samples were then immersed in water 
with an immediate change of white colour membrane to a transparent film (Figure 4.11). This 
indicates that the fibrous structure of the membrane was lost and that after UV crosslinking the 
membranes were still water-soluble. 
However, from Figure 4.11 it is not clear what happens to the membrane structure after 
immersion, so samples (after immersed) were analysed on SEM (Figure 4.12) to study the struc-
ture of the membrane with the UV crosslinking time. With the SEM analysis we see that samples 
with increased UV exposure have more tendency to completely lose their desired fibrous struc-
ture, turning it into a film. Already with 30 min and 1 h, the differences are clear and with 2 h UV 
it is no longer possible to observe any fibrous structure. 
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Figure 4.11. Plain PVP 18 wt.% membranes with different UV crosslinking times after immersed in water. 
As for the thermal crosslinking, samples were initially crosslinked with temperatures of 
200 ºC and 175 ºC and 1.5 and 10 h. However, the temperature control was difficult, and samples 
were scorched (turned into dark brown) and fibres lost their morphology and structure. The tem-
perature was decreased to 150 ºC for 5, 10, 15, 20 and 24 h. With this treatment conditions the 
membrane was not scorched and when immersed in water, did not dissolve. Through SEM anal-
ysis, the structure and morphology of the fibres were evaluated. Figure 4.13 shows SEM images 
of plain PVP membranes after thermal crosslinking. Comparing a plain PVP membrane before 
and after crosslinking at 150 ºC at different times after immersion, confirms the maintenance of 
the fibrous structure for times above 20 h. At 5 h, the structure is practically fully destroyed, while 
after 10 h it starts getting possible to see a fibrous look alike structure. After 15 h a fibrous struc-
ture is maintained but the fibres are still affected by the water absorption. After 20 h and 24 h the 
differences are very small, and a fibrous structure is fully maintained. 
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Figure 4.12. SEM analysis of the respective PVP 18 wt.% membranes with different UV times in Figure 
4.11 after immersed in water. 
 
Figure 4.13. PVP membrane without treatment before immersion, and PVP membranes with thermal cross-
linking of 150ºC with different cross-linking times, after immersion (note: To be able to properly observe 
the structure different magnifications had to be used for each sample, therefore the magnification used 
should not be considered). 
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Based on these results, composite membranes were crosslinked at 150 ºC for 24 h. Figure 
4.14 shows SEM images of plain PVP, PVP/BAG and PVP/BAG/IONPs membranes before and 
after thermal crosslinking. The crosslinked membranes were immersed in ultra-pure water to test 
their solubility, and unlike the non-crosslinked membranes, they did not dissolve instantly. They 
were then immersed in water for 24 h and dried at 40 ºC. In Figure 4.14, we can see their micro-
structure through SEM images. Comparing these images with the respective membranes before 
immersion in water, we can observe some swelling of the fibres. This swelling change the fibres 
morphology and dimension which might change the membranes bioactivity and mechanical prop-
erties, as they are directly influenced by the surface area and consequently the diameter and shape 
of the fibres. This swelling capacity should be quantified by measuring the amount of water that 
the membrane can absorb in an established period of time. Also, with this analysis it is not clear 
if the membranes are fully water insoluble. The membranes seem to not dissolve in the naked eye, 
but there is the possibility that some part of the membrane is lost to the solvent. A study measuring 
the mass of the solvent and of the membrane before and after immersion should provide this 
information about the membrane properties. 
 
Figure 4.14. PVP, PVP BG, PVP BG IONP´s membranes observed on SEM, before and after crosslinking 
at 150 ºC for 24 h, and after 24 h immersion in ultra-pure water and drying. 
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4.3 Magnetic hyperthermia Assays 
Magnetic hyperthermia assays were performed to evaluate the heating capacity of the 
IONPs alone and IONPs in the PVP/BAG membranes, in the presence of an alternating magnetic 
field. All assays were performed during 10 minutes with a magnetic flux density of 300 Gauss 
and a frequency of 418.5 kHz. Figure 4.15 represents the temperature variation for assays on a 1 
ml aqueous solution with 4% IONPs. Three assays were performed, giving an average tempera-
ture variation of 22 ºC ± 1.8ºC. Samples of 10 and 20 mg of a PVP/BAG/IONPs composite mem-
brane were tested (Figure 4.15). The concentration of IONPs in the membrane (4% of the polymer 
mass) is lower than in the aqueous solution (4% of the solution), therefore lesser NPs are present 
on the membrane samples, therefore lower temperature variation were expected as confirmed 
with average temperature variations of 0.7 ± 0.15 ºC for 10 mg of membrane and 2 ± 0.36 ºC for 
20 mg of membranes. 
 
Figure 4.15. Temperature variation (ºC) from magnetic hyperthermia assays for IONPs in 4% aqueous 
solution, 10 and 20 mg of 14 wt.% PVP, 14 wt.% BAG, and 4 wt.% IONPs. 
The increase of heating capacity (1.3 ºC) with the double of membrane mass (and conse-
quently double IONPs) is also stated. If the normal body temperature is considered to be 37ºC, a 
temperature variation of 0.7 ºC (10 mg membrane) and 2 ºC (20 mg membrane) would not be 
enough to reach the desired therapeutic temperature for magnetic hyperthermia on cancer tissue 
(between 40 and 44 ºC), without more membrane mass or IONPs concentration. Nevertheless, the 
incorporation of IONPs in a polymeric bioactive glass membrane was successful and added a new 
property (potentially useful for magnetic hyperthermia treatment) to the membrane. 
4.4 Bioactivity Assays in SBF 
The bioactivity assays are performed on materials as a reference for further evaluating in 
vivo bioactivity using animals or other sources. The thickness, coverage, form of apatite and time 
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taken to deposit apatite are often estimated. Figure 4.16 shows the evaluation of a PVP 14 wt.% 
and BAG 14 wt.% composite membrane in different immersion times on SBF. BAG particles 
observed in non–immersed membrane are thought to start forming apatite, as this is the BAG 
purpose in the composite. However, with increasing immersion times it is not possible to observe 
these particles anymore. From 6 to 12 h we can observe a slight difference where a film starts 
forming after 12 h immersion in SBF. This film formation may be due to the apatite formation 
and after 24 h this effect is aggravated; however, this is not coherent in the following images. 
To further analyse the formation of apatite on the membrane, FTIR and DRX analysis 
should be used to chemically confirm the apatite formation. The soluble species of silica, phos-
phate and calcium concentrations in SBF before and after immersing the membrane should also 
be measured to assess the SBF uptake of the species. This measurement could give a more precise 
estimative of the time taken by the membrane to dissolute each of the species and consequently 
the time taken to form apatite on the membranes. 
 
Figure 4.16. SEM images of the PVP 14 wt.% and BAG 14 wt.% after 6, 12, 24, 48 and 72 h immersion in 
SBF. 
4.5 Cytotoxicity Assays 
In order to ascertain the biocompatibility of the PVP membranes with BAG and IONPs, 
the potential cytotoxic effect of these membranes on Vero cells was evaluated using the extract 
method (ISO standard 10993-5). The results are shown in Figure 4.17 which expresses cell via-
bility in %. The cell viability (%) was determined following the procedure in supplementary in-
formation. The assays were performed for an extract concentration of 16 mg/ml with an uncer-
tainty of 5 %. Two dilutions (factor 2) were performed for each membrane and 5 replicas for each 
sample. The control medium shows a cell viability around 100% and was used as reference for 
the following samples. All pure PVP samples revealed no cytotoxicity with cell viability (%) of 
92 % (for normal concentration) and 96 % (for dilution 1) and 91 % (for dilution 2), proving the 
expected biocompatibility of the PVP. 
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The BAG (14 wt.% PVP, 14 wt.% BAG membrane) revealed to be moderately cytotoxic 
for the cells with 72 ± 6 % cell viability. Following dilutions BAG D1 and BAG D2 proved to 
increase cell viability to 81 ± 2% and 87±3 %. Although both values are labelled as slightly cy-
totoxic, D2 is very close to being considered non cytotoxic. Thus, given the biocompatibility of 
PVP, the cytotoxicity of these samples is dependent on BAG presence. The fact that both dilutions 
increased cell viability suggests that the concentration of BAG can be tuned to show no cytotox-
icity. 
IONPs membrane (14 wt.% PVP, 14 wt.% BAG, 4 wt.% IONPs) also showed a moderately 
cytotoxic behaviour for the Vero cells with 78 ± 4% cell viability. Dilution 1 improved for 81 ± 
5 % (slight cytotoxic) and Dilution 2 increased to 88 ± 5 % and can be considered non cytotoxic. 
These results are similar to the BAG membrane, which might suggest that this particular IONPs 
concentration has no effect on the cell viability. A study carried out by the research group has 
proven possible to produce non-cytotoxic membranes with these NPs [4], which again points to 
the cytotoxicity of BAG. 
The pH of BAG membrane extract concentration was tested with a colorimetric test on site 
and it confirmed an alkaline pH. It is possible that the alkyne nature of BAG present in the mem-
branes may have affected the cells proliferation, during the test. To confirm this, BAG pH should 
be controlled during synthesis and placed in a dialysis process until it turns neutral and the cyto-
toxicity assays should be repeated in the same conditions. 
  
Figure 4.17. Vero cell viability (%) after indirect exposure to the different electrospun membranes. PVP 
corresponds to plain PVP 18 wt.% membrane; BAG corresponds to composite PVP 14 wt.% and BAG 14 
wt.% membrane; and IONPs correspond to composite PVP 14 wt.%, BAG 14 wt.% and IONPs 4 wt.% and 
respective dilutions 1 and 2 (factor 2). 
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5 Conclusions and future perspectives 
This work had as its central objective the production and characterization of a composite 
membrane of non-sintered BAG, IONPs and biodegradable PVP by the electrospinning tech-
nique, and respective process optimization, so that they can be used in cancer therapy through 
magnetic hyperthermia and bone regeneration. 
Producing a non-sintered BAG represents an advantage in terms energetic costs as it does 
not require high temperatures. However, the presence of the structural agent may originate some 
problems in properly characterizing this material, as the presence of F127 was found to possibly 
mask some characteristics of the silica, calcium and phosphate species. This made it hard to fully 
understand of the phenomenon reported in this work.  
SEM analysis of the fibres showed the effects of the different parameters (flow rate, applied 
voltage, needle-collector distance and humidity) on the morphology and average size of the fibres 
of PVP BAG composite membrane. After experimenting low BAG concentrations within the pol-
ymeric solution and reducing the BAG particle size it was shown that the BAG concentration 
could be augmented up to a 14 wt.% concentration, and it is thought to be possible to increase 
this concentration even more, while adjusting the polymer concentration. After selecting the low-
est average fibre sizes and the most practical parameters, 20 kV, 20 cm, 0, 15 ml/h and humidity 
% levels around 30 – 40 % were selected to produce PVP 14 wt.% and BAG 14 wt.% membranes. 
As IONPs were easily incorporated in the membrane without changing the solution viscosity, the 
same parameters were used for the PVP BAG IONP´s membranes. 
A study regarding the membranes crosslinking was performed by testing two different 
crosslinking processes. UV cross-linking did not show any signs of properly reticulating the mem-
brane and was quickly abandoned. Thermal crosslinking on the other hand proved to be a suitable 
process, as a 150 ºC for 24 h treatment proved to turn the membranes into water-insoluble mate-
rials.  
Through magnetic hyperthermia assays, the membranes with IONPs revealed the (small) 
ability to generate heat under an alternative magnetic field stimulus and confirmed the successful 
incorporation of the IONPs in the membrane without the IONPs losing their super paramagnetic 
properties. The quantity of IONPs was shown to influence the hyperthermia performance and 
with further studies, can be tuned to generate enough proper heat for clinical applications. 
The bioactivity assays were inconclusive as the process variants and components must be 
much more supervised. It seems that there is an ionic exchange between the membrane and SBF, 
but further analysis must be performed to confirm this. 
Regarding the cytotoxicity assays, BAG concentration proved to add some cytotoxicity to 
this system. Only with a second dilution from the original extract concentration, was possible to 
obtain a non-cytotoxic sample. This cytotoxicity from the BAG was attributed to its alkaline pH, 
which means that a dialysis step must be added to the BAG synthesis.  
Overall, it was possible to produce a composite membrane as intended and which can serve 
as support for a more efficient delivery of NPs, but although the membranes showed some poten-
tial regarding magnetic hyperthermia, they seemingly lacked the also desired bioactive properties. 
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A low bioactive performance was expected, as neither the BAG nor the fibres themselves have 
micro or Nano porosity, which is a very crucial property for this matter, but the analysis were not 
conclusive and not promising at all, as we conclude that the exploration of new alternatives should 
be prioritized to the detriment of the alternative presented here in this work.  
5.1 Future Perspectives 
Like is was stated above, this work was performed in parallel with a PhD student and some 
of the studies here presented may give some information regarding the production of a composite 
with the same intended characteristics. 
Regarding magnetic hyperthermia treatment, it is important to understand the heat gener-
ating mechanisms of the IONPs as they generate heat from the Néel relaxation (rotation of the 
nanoparticle internal dipole) and Brownian relaxation (physical rotation of the nanoparticle). In 
the membrane it is possible that the Brownian relaxation does not occur, because the IONPs are 
trapped and therefore the hyperthermia performance of the IONPs in the membrane will not match 
free IONPs. It would be important to study the variation of the hyperthermia performance, of an 
immersed membrane, with the time. If the IONPs escape from the membrane into the solution, 
the Brownian relaxation will return and count to the hyperthermia effect.  
New incorporation methods should also be tested. A more efficient incorporation means a 
higher amount of IONPs in the membrane and a better control of the hyperthermia effect. 
Regarding the BAG, as referred above the micro and nano porosity are crucial to the high 
bioactivity and cell attachment performance, therefore ensure these properties is a must in future 
studies, whether by calcination of the BAG during the synthesis, or by calcination of the fibrous 
membrane with the BAG inside. In this last strategy, a higher BAG concentration may be re-
quired, because if the membrane is majorly composed by a polymer, the polymer will be removed 
during the calcination process and only the BAG will remain. 
The membranes should also be mechanically characterized. For chirurgical implantation 
the membranes need to malleable and resistant, therefore studying and improving these properties 
is also very important. 
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6 Supporting information 
6.1 Tested electrospinning parameters 
Table 6.1. Electrospinning parameters tested using different concentrations of BAG in an 18 wt.% PVP 
solution in ethanol. 
Sample 
BAG 
wt.% 
Flow Rate 
(ml/h) 
Applied Voltage 
(KV) 
Needle-collector 
distance (cm) 
Humidity 
% 
Temperature 
(ºC) 
A1 
1 
0,2 
15 
15 24 
25 
A2 20 27 
A3 
20 
15 24 
A4 20 24 
A5 
0,4 
15 
15 24 
A6 20 25 
A7 
20 
15 24 
A8 20 28 
B1 
2 
0,2 
15 
15 24 
25 
B2 20 28 
B3 
20 
15 25 
B4 20 28 
B5 
0,4 
15 
15 24 
B6 20 24 
B7 
20 
15 24 
B8 20 24 
C1 
3 
0,2 
15 
15 30 
25 
C2 20 30 
C3 
20 
15 30 
C4 20 30 
C5 
0,4 
15 
15 30 
C6 20 30 
C7 
20 
15 28 
C8 20 30 
D1 
4 
0,2 
15 
15 30 
25 
D2 20 30 
D3 
20 
15 29 
D4 20 30 
D5 
0,4 
15 
15 29 
D6 20 30 
D7 
20 
15 30 
D8 20 29 
 
35 
E1 
5 
0,2 
15 
15 30 
25 
E2 20 29 
E3 
20 
15 30 
E4 20 30 
E5 
0,4 
15 
15 30 
E6 20 30 
E7 
20 
15 30 
E8 20 30 
 
Table 6.2. Set of electrospinning parameters tested using a solution of 14 wt.% PVP and 14 wt.% BAG 
(both relative to solvent mass) in a mixture of ethanol:water in a ratio of 85:15 (v/v). 
Sample Number 
Flow Rate 
(ml/h) 
Voltage Applied 
(kV) 
Needle-Collector 
Distance (cm) 
Humidity 
1 
0.05 
15 
15 
38 
2 18 
3 20 
4 
18.3 
15 
5 18 
6 20 
7 
20 
15 
8 18 
9 20 
37 
10 
0,15 
15 
15 
11 18 
12 20 
13 
18.3 
15 
14 18 
15 20 
16 
20 
15 
17 18 
18 20 
35 
19 
0,25 
15 
15 
20 18 
21 20 
22 
18.3 
15 
23 18 
24 20 
25 
20 
15 
26 18 
27 20 
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6.2 Procedure for in vitro cytotoxicity evaluation 
The cytotoxicity study was performed using the extract method which consists of placing 
the cells in contact with the medium where the membranes were previously incubated. To deter-
mine the number of viable cells, a colorimetric method based on the resazurin reagent was used, 
which is reduced by the living cells. For the extract production, different samples of 40 mg ± 5% 
were pre-sterilized with UV irradiation for 1 hour. Subsequently, each membrane was placed in 
2.5 ml of medium, at 37 ºC, for 48 hours. Cells were seed into 96-well plates (Figure 6.1) and 15 
wells were used for each type of membrane (45 wells total: 5 replicas for the initial concentration 
of extract medium 16 mg/ml and 5 replicas for each of 2 dilutions of factor 2 from the initial 
concentration). In addition, negative (column 1, 5 replicas), positive (column 11, 3 replicas) and 
cell-mediated controls (column 1, 3 replicas) were performed, serving as reference for calculating 
cell viability. 
 
Figure 6.1. Schematic planning for cytotoxicity assays. 
The plate was again placed in the incubator for 48 h. Resazurin was used for cell viability 
analysis. After 48 hours in the incubator, the plate was removed and as well as the medium con-
tained in each well. A solution of 90% of medium and 10% resazurin was then placed in each 
well. The viability analysis consists of a change in the colour of the solution (a pink colour means 
live cells and a blue colour means the presence of dead cells. The plate was placed in the incubator 
for 4 hours. After this time, the absorbances of each well (at 570 nm and 600 nm) were measured 
in a Biotek ELX800 microplate reader. To determine the cell viability %, medium control and 
uncertainties, the means of each 5 replicates were calculated for each sample and the following 
expressions were used: 
Medium Control = "Average 𝑖"−"Average 𝐶𝑀" 
Cell Viability = 
"𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙"
"Average C-" −"𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝑀"
 
Uncertainty = √𝜎2 + 𝜎𝐶𝑀
2  
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Where σ represents the standard deviation for each of the concentrations used and σCM is 
the standard deviation of the control medium. In order to analyse cell viability, it is necessary to 
take into account four denominations according to the percentage of viability obtained and they 
are: viability greater than 90 % the material is non-cytotoxic; with cell viability between 80% and 
89 % considered to be slightly cytotoxic; between 50 % and 79 % is moderately cytotoxic; if it is 
less than 50 % is severely cytotoxic. 
 
6.3 SEM/EDS elements colour trace of composite membranes 
(PVP/BAG) 
 
Figure 6.2. SEM/EDS elements colour trace attached to Figure 4.8. 
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6.4 SEM/EDS elements colour trace of composite membranes 
(PVP/BAG/IONPs) 
 
Figure 6.3. SEM/EDS elements colour trace attached to Figure 4.10. 
 
